Interactive Transcript
0:01
So while BI RADS 3 is a challenging topic overall, I think that
0:05
MRI is really the hardest topic with BI RADS 3 because it's a
0:09
newer field and the data is a lot less robust than on mammogram
0:13
and ultrasound. I did show a few examples of some cases that there
0:18
is some data to support the use of BI RADS 3 and I
0:21
just want to go over those. So just to start, like I said,
0:25
this is really an evolving area and I think we want to be
0:29
flexible with our use of BI RADS 3 on MRI and be following
0:33
the literature because I think that this is going to be really clarified
0:36
over the next couple of years. The fifth edition of BI RADS was
0:40
published in 2013 and MRI has, the technology itself has improved since
0:46
2013. We're also just doing a lot more breast MRI
0:51
now than we were in 2013. So this is becoming more and more
0:55
relevant. But the 2013 atlas, this is what it lists for reasons to
1:00
give a BI RADS 3 on MRI. So first it includes background parenchymal enhancement.
1:05
In the atlas it says to consider giving a BI RADS 3 when
1:08
there's suboptimal timing based on menstrual status or for postmenopausal
1:14
patients on hormone replacement therapy. They include a
1:19
dominant focus that is T2 hypo intense on baseline MRI
1:24
and for masses and oval around circumscribed mass on a baseline MRI.
1:29
And then they say that in the atlas it says that there's insufficient evidence
1:33
for non mass enhancement. So there's emerging data that, you know, this
1:39
is not in BI RADS yet. And hopefully when a new BI RADS comes
1:42
out, there'll be better guidance. But the more updated literature suggests
1:47
that we don't need to use BI RADS 3 for background parenchymal enhancement.
1:51
There is with the newer contrast agents, we have not shown that there's
1:56
large variations in the timing based on menstrual status.
2:02
And we should really, if we see a diffuse pattern of background parenchymal
2:06
enhancement, we should be able to assess that as a BI RADS 2. If
2:10
there's any areas that stand out and look separate,
2:14
we should give it a BI RADS 4 and do a biopsy.
2:17
But that the space for really doing a short term follow up for
2:19
background parenchymal enhancement has really gone away. The foci in mass,
2:25
the data has continued to support those two, and I showed examples of
2:28
these two findings that are reasonable for a BI RADS 3 assessment. So
2:33
just to repeat again, we see a dominant focus, so this should be
2:37
a single focus that stands out compared to the rest of the background
2:41
parenchymal enhancement. And it should be T2 hypo intense, and it should
2:47
be on a baseline MRI or one with less than two years of
2:50
follow up. We're going to follow it for two years. If it's T2 bright, then
2:54
we can consider that benign. And if it's a new or increasing
3:00
enhancing focus, then we want to give it a BI RADS 4 and biopsy.
3:04
For masses, as I showed that kind of similar to mammogram and ultrasound
3:10
when there is an oval or round circumscribed mass on a baseline MRI, it's
3:17
reasonable to give that a BI RADS 3 and follow.
3:21
Again, we really want to be careful looking for any changes in size
3:25
and have a low threshold to change that to a BI RADS 4 and
3:30
do a biopsy. And non mass enhancement continues to be a really challenging
3:37
topic. There's very limited data on this, but there is some small studies
3:43
and there's also some expert opinion that suggests that focal regional homogenous
3:50
non mass enhancement without associated T2 hyperintensity may be appropriate
3:56
for a BI RADS 3 assessment. So I did show an example of
3:59
that, but I just want to emphasize that there's not really robust data
4:02
to support this. And we'll really need to continue following the literature
4:07
and studying this topic to clarify which cases of non mass enhancement we
4:12
can safely give a BI RADS 3 to
4:17
and follow rather than biopsy and which cases we can consider to be
4:22
just part of the normal background enhancement and give a BI RADS 2.
© 2024 MRI Online. All Rights Reserved.